相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Survival, Causes of Death, and Prognostic Factors in Systemic Sclerosis: Analysis of 947 Brazilian Patients
Percival D. Sampaio-Barros et al.
JOURNAL OF RHEUMATOLOGY (2012)
Ly6Chi Monocytes Direct Alternatively Activated Profibrotic Macrophage Regulation of Lung Fibrosis
Michael A. Gibbons et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung Disease
Michael D. Roth et al.
ARTHRITIS AND RHEUMATISM (2011)
Interferon and Alternative Activation of Monocyte/Macrophages in Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Romy B. Christmann et al.
ARTHRITIS AND RHEUMATISM (2011)
Lung Tissues in Patients With Systemic Sclerosis Have Gene Expression Patterns Unique to Pulmonary Fibrosis and Pulmonary Hypertension
Eileen Hsu et al.
ARTHRITIS AND RHEUMATISM (2011)
Serum CC chemokine ligand-18 predicts lung disease worsening in systemic sclerosis
K. P. Tiev et al.
EUROPEAN RESPIRATORY JOURNAL (2011)
TGF-beta driven lung fibrosis is macrophage dependent and blocked by Serum amyloid P
Lynne A. Murray et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2011)
Integrating mechanisms of pulmonary fibrosis
Thomas A. Wynn
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Local apoptosis promotes collagen production by monocyte-derived cells in transforming growth factor beta 1-induced lung fibrosis
Xueyan Peng et al.
FIBROGENESIS & TISSUE REPAIR (2011)
Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database
Anthony J. Tyndall et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Type I interferon system activation and association with disease manifestations in systemic sclerosis
Maija-Leena Eloranta et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Alternatively activated alveolar macrophages in pulmonary fibrosis-mediator production and intracellular signal transduction
Dmitri V. Pechkovsky et al.
CLINICAL IMMUNOLOGY (2010)
Circulating monocytes from systemic sclerosis patients with interstitial lung disease show an enhanced profibrotic phenotype
Susan K. Mathai et al.
LABORATORY INVESTIGATION (2010)
Limited Systemic Sclerosis Patients with Pulmonary Arterial Hypertension Show Biomarkers of Inflammation and Vascular Injury
Sarah A. Pendergrass et al.
PLOS ONE (2010)
Predictors of interstitial lung disease in early systemic sclerosis: a prospective longitudinal study of the GENISOS cohort
Shervin Assassi et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Serum CC-Chemokine Ligand 18 Concentration Predicts Outcome in Idiopathic Pulmonary Fibrosis
Antje Prassel et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2009)
Cartilage oligomeric matrix protein expression in systemic sclerosis reveals heterogeneity of dermal fibroblast responses to transforming growth factor β
G. Farina et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Centrilobular Fibrosis: An Underrecognized Pattern in Systemic Sclerosis
Romy B. C. de Souza et al.
RESPIRATION (2009)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Induction of interferon-α by scleroderma sera containing autoantibodies to topoisomerase I
Daniel Kim et al.
ARTHRITIS AND RHEUMATISM (2008)
High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease
Jonathan G. Goldin et al.
CHEST (2008)
Molecular Subsets in the Gene Expression Signatures of Scleroderma Skin
Ausra Milano et al.
PLOS ONE (2008)
Changes in causes of death in systemic sclerosis, 1972-2002
Virginia D. Steen et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A macrophage marker, Siglec-1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type I Interferons and Toll-like receptor agonists
Michael R. York et al.
ARTHRITIS AND RHEUMATISM (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Application of false discovery rate procedure to pairwise comparisons of refractive index of glass fragments
M. Pawluk-Kolc et al.
FORENSIC SCIENCE INTERNATIONAL (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
A vicious circle of alveolar macrophages and fibroblasts perpetuates pulmonary fibrosis via CCL18
A Prasse et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Gene expression profiles distinguish idiopathic pulmonary fibrosis from hypersensitivity pneumonitis
M Selman et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2006)
Involvement of CC chemokine ligand 18 (CCL18) in normal and pathological processes
E Schutyser et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
Mortality in systemic sclerosis: an international meta-analysis of individual patient data
JPA Ioannidis et al.
AMERICAN JOURNAL OF MEDICINE (2005)
Eosinophils and monocytes produce pulmonary and activation-regulated chemokine, which activates cultured monocytes/macrophages
I Schraufstatter et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2004)
Pulmonary and activation-regulated chemokine stimulates collagen production in lung fibroblasts
SP Atamas et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2003)
Predictors of end stage lung disease in a cohort of patients with scleroderma
C Morgan et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Gene expression in bronchoalveolar lavage cells from scleroderma patients
IG Luzina et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2002)
Centrilobular fibrosis: A novel histological pattern of idiopathic interstitial pneumonia
MEP de Carvalho et al.
PATHOLOGY RESEARCH AND PRACTICE (2002)
Human recombinant inteuferon-α2a and interferon-αA/D have different effects on bleomycin-induced lung injury
N Berkman et al.
RESPIRATION (2001)